[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/) › [Gynaecological oncology](https://durgical.com/en/obstetrics-gynaecology/areas/gyn-oncology/) › HPV vaccination

# HPV vaccination

- Method or treatment

One injection before the start of sexual life prevents most cervical cancers. It is one of the most powerful cancer-prevention tools medicine has.

Updated Nov 15, 2026

**See it in 3D:** [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/) · [External os](https://durgical.com/en/anatomy/external-os-of-uterus/)

## Key points

- Virus-like particles of L1 protein: no DNA, cannot infect.
- Primary target: girls 9 to 14 before sexual debut; boys too.
- WHO 2022: one dose is enough for healthy people up to 20; at least two for the immunocompromised.
- Prevents infection; does not treat it.
- Vaccinated women are still screened.

On this page

- The basics Key points
- What it is
- How to think about it
- How it works and how well
- Step by step
- Risks and who should not use it
- Next step / Follow-up
- Common traps
- Elsewhere in DurgiPedia

- Treatment The three vaccines

- Study Test yourself

- Connections Connections

## What it is

HPV vaccines contain virus-like particles made of the L1 capsid protein of [human papillomavirus](https://durgical.com/en/microbiology/human-papillomavirus/); they have no viral DNA and cannot cause infection. They induce neutralising [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/) that stop the virus entering the basal cells of the [cervix](https://durgical.com/en/anatomy/cervix-of-uterus/) and other epithelia. The bivalent vaccine covers types 16 and 18, which cause about 70% of cervical cancers; the quadrivalent adds 6 and 11 ([genital warts](https://durgical.com/en/obstetrics-gynaecology/genital-warts/)); the nonavalent adds five more high-risk types. They prevent infection; they do not clear an existing one. WHO's 2022 position: the primary target is girls aged 9 to 14 before sexual debut, and a single dose gives protection comparable to two doses in healthy girls and young women. Colombia's national programme uses a single dose for healthy children and two doses only for immunosuppressed people (MinSalud, since 30 September 2023).

## How to think about it

The vaccine is a lock on a door the virus has not yet opened. It blocks entry very well, but it cannot evict a virus that is already inside. That is why it is given before sexual life begins, why it does not treat existing lesions, and why vaccinated women are still screened.

## How it works and how well

- Efficacy against infection and precancer from the vaccine types is above 90% in people vaccinated before exposure; countries with high coverage have seen falls in [cervical precancer](https://durgical.com/en/conditions/cervical-intraepithelial-neoplasia/) and cancer.
- WHO schedule options (2022): one or two doses for girls aged 9 to 14 and for girls and women 15 to 20; two doses for women over 21; at least two, ideally three, for people who are immunocompromised or living with HIV.
- Boys and men can be vaccinated: it protects against genital warts and anal, penile and oropharyngeal cancers and reduces transmission.
- Colombia (MinSalud operational guidelines, 2024): a single dose for healthy children in the programme's age groups and two doses six months apart for immunosuppressed children; check the current national schedule for the ages covered.
- The vaccine is free in the national immunisation programme.

## Step by step

- The vaccine's L1 proteins self-assemble into empty shells that look like the virus but carry no DNA.
- The immune system sees a dense, repetitive viral surface and makes high levels of neutralising antibody, even after one dose.
- Antibody seeps from blood onto the genital epithelium, especially at small breaks where the virus enters.
- Antibody binds the virus before it reaches the basal cells, so infection never starts.
- No persistent infection means no E6/E7 activity, no precancer and no cancer from the vaccine types.

## The three vaccines

| Vaccine | HPV types | What it prevents |
| --- | --- | --- |
| [Bivalent](https://durgical.com/en/conditions/cervical-cancer/) | 16, 18 | About 70% of cervical cancers |
| [Quadrivalent](https://durgical.com/en/conditions/human-papillomavirus-infection/) | 6, 11, 16, 18 | The same cancers plus most genital warts |
| [Nonavalent](https://durgical.com/en/conditions/cervical-cancer/) | 6, 11, 16, 18, 31, 33, 45, 52, 58 | About 90% of cervical cancers plus warts |

## Risks and who should not use it

- Common side effects: pain and swelling at the site, headache, and fainting in adolescents; vaccinate seated and observe for about 15 minutes.
- Contraindication: a severe allergic reaction to a previous dose or a vaccine component (the quadrivalent and nonavalent vaccines contain yeast proteins).
- Not recommended during pregnancy as a precaution; if given by mistake, no harm has been shown and the pregnancy needs no special measures.
- Large safety reviews (WHO Global Advisory Committee on Vaccine Safety) have found no link with autoimmune disease, infertility or chronic fatigue.
- It is not a treatment for warts, CIN or cancer, though it may reduce recurrence after treatment of high-grade lesions.

## Next step / Follow-up

- Check the record at every contact with a child or adolescent aged 9 or over and vaccinate if a dose is missing, following the current national schedule.
- Answer parents' safety questions with clear data: the vaccine contains no virus DNA, and fainting is a needle reaction, not a vaccine injury.
- Vaccinated women still need [cervical screening](https://durgical.com/en/nursing/screening-in-women-s-health-cervical-cancer-breast-cancer-and-the-res-3280-sched/) at the ages of the national programme.
- Report suspected serious adverse events to the national vaccine safety surveillance system.
- Offer vaccination to people with HIV or immunosuppression with the extra doses their schedule requires.

## Common traps

- **Stopping screening in vaccinated women**: vaccines do not cover all high-risk types, and some women were already infected.
- **Refusing to vaccinate a sexually active adolescent**: she may not yet have met the vaccine types and still benefits.
- **Thinking a single dose is a shortcut that gives weaker protection**: WHO judged it comparable to two doses in healthy young people.
- **Using it as treatment**: it prevents new infections but does not clear existing ones.

## Test yourself

Think of the answer, then tap the question to see it.

## Why is HPV vaccination targeted at girls aged 9 to 14?

It prevents infection but does not clear it, so it works best before sexual debut; young adolescents also produce a strong immune response.

## A 23-year-old vaccinated at 11 asks if she can skip cervical screening. What do you tell her?

No: the vaccine covers most but not all high-risk types, so she still needs screening at the ages of the national programme.

## Can the HPV vaccine cause HPV infection or cancer?

No. It contains only empty L1 protein shells without viral DNA, so it cannot infect cells.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/obstetrics-gynaecology/hpv-vaccination/)

## Elsewhere in DurgiPedia

- [Giving vaccines safely and Colombia's PAI schedule](https://durgical.com/en/nursing/giving-vaccines-safely-and-colombia-s-pai-schedule/)
- [HPV and cervical carcinogenesis](https://durgical.com/en/general-pathology/hpv-and-cervical-carcinogenesis/)
- [Vaccine types: live, inactivated, subunit, toxoid, mRNA, vector](https://durgical.com/en/immunology/vaccine-types-live-inactivated-subunit-toxoid-mrna-vector/)

## Connections

## See it in 3D 2

The structures of Durgical's 3D anatomy where it is found.

- [Cervix](https://durgical.com/en/anatomy/cervix-of-uterus/)
- [External os](https://durgical.com/en/anatomy/external-os-of-uterus/)

## Related 3

- [Cervical cancer screening with HPV testing in Colombia](https://durgical.com/en/obstetrics-gynaecology/cervical-cancer-screening-with-hpv-testing-in-colombia/)
- [Cervical cancer: FIGO staging and treatment in outline](https://durgical.com/en/obstetrics-gynaecology/cervical-cancer-figo-staging-and-treatment-in-outline/)
- [Genital warts](https://durgical.com/en/obstetrics-gynaecology/genital-warts/)

## Related conditions 3

- [Human papillomavirus (HPV) infection](https://durgical.com/en/conditions/human-papillomavirus-infection/)
- [Cervical cancer](https://durgical.com/en/conditions/cervical-cancer/)
- [Cervical intraepithelial neoplasia (cervical dysplasia)](https://durgical.com/en/conditions/cervical-intraepithelial-neoplasia/)

## Microorganisms 1

- [Human papillomavirus](https://durgical.com/en/microbiology/human-papillomavirus/)

## In Pharmacology 1

- [Human papillomavirus (HPV) vaccine](https://durgical.com/en/pharmacology/human-papillomavirus-vaccine/)

[← All of obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: [Human papillomavirus vaccines: WHO position paper, December 2022](https://www.who.int/publications/i/item/who-wer9750-645-672) (World Health Organization (Weekly Epidemiological Record), 2022); [WHO updates recommendations on HPV vaccination schedule](https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule) (World Health Organization, 2022); [Human papillomavirus and cancer (fact sheet)](https://www.who.int/news-room/fact-sheets/detail/human-papilloma-virus-and-cancer) (World Health Organization, 2024); [Human Papillomavirus](https://www.ncbi.nlm.nih.gov/books/NBK448132/) (StatPearls Publishing (NCBI Bookshelf), 2024); [Alcance a los lineamientos técnicos y operativos para la vacunación contra el virus del papiloma humano (VPH)](https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/alcance-lineamientos-operativos-vacunacion-papiloma-humano-colombia.pdf) (Ministerio de Salud y Protección Social de Colombia, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/obstetrics-gynaecology/hpv-vaccination/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/obstetrics-gynaecology/hpv-vaccination/
